Sign in

CIK 0000812796

  • Non-accelerated filer
  • Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411505029
Phone
+1 609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-05-19 Warusz Joseph Michael VP of Admin, Controller / PAO Exercise or conversion +4,690 $0.64 $3K 4,690
2014-05-19 Warusz Joseph Michael VP of Admin, Controller / PAO Exercise or conversion · Option (Right to Buy) −4,690 25,310
2014-05-14 Brownlie Keith L Director Exercise or conversion +16,667 $0.30 $5K 35,714
2014-05-14 Brownlie Keith L Director Exercise or conversion · Option (Right to Buy) −16,667 8,333
2014-05-13 SCHABER CHRISTOPHER J Chairman, CEO and President Exercise or conversion +7,815 $0.64 $5K 67,496
2014-05-13 SCHABER CHRISTOPHER J Chairman, CEO and President Exercise or conversion · Option (Right to Buy) −7,815 112,185
2014-01-06 Straube Richard Senior VP & CMO Grant or award · Stock Option (Right to Buy) +100,000 100,000
2013-12-05 Warusz Joseph Michael VP of Finance and Acting CFO Grant or award · Stock Option (Right to Buy) +45,000 45,000
2013-12-05 SCHABER CHRISTOPHER J Chairman, CEO and President Grant or award · Stock Option (Right to Buy) +100,000 100,000
2013-12-05 Brughera Marco Maria Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2013-12-05 BREY ROBERT N Chief Scientific Off., Sr. VP Grant or award · Stock Option (Right to Buy) +10,000 10,000
2013-09-27 LAPOINTE ANTHONY GREGG Director Grant or award · Stock Option (Right to Buy) +13,275 13,275
2013-09-27 ZELDIS JEROME B Director Grant or award · Stock Option (Right to Buy) +13,275 13,275
2013-09-27 RUBIN ROBERT J. Director Grant or award · Stock Option (Right to Buy) +13,275 13,275
2013-09-27 Brownlie Keith L Director Grant or award · Stock Option (Right to Buy) +13,275 13,275
2013-09-25 Warusz Joseph Michael VP of Finance & Acting CFO Grant or award · Stock Option (Right to Buy) +55,000 55,000
2013-09-25 SCHABER CHRISTOPHER J Chairman, CEO & President Grant or award · Stock Option (Right to Buy) +130,000 130,000
2013-09-25 HORGAN KEVIN Chief Medical Officer & Sr. VP Grant or award · Stock Option (Right to Buy) +85,000 85,000
2013-09-25 BREY ROBERT N Chief Scientific Offr & Sr. VP Grant or award · Stock Option (Right to Buy) +35,000 35,000
2013-06-25 ZELDIS JEROME B Director Purchase +23,809 $1.05 $25K 48,809

Page 12 of 14 · 277 trades